Patents by Inventor Ryan Patrick OWEN

Ryan Patrick OWEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260167743
    Abstract: The present disclosure provides methods and kits for treating or preventing an allergic reaction to a food allergen consumed by a human subject with one or more food allergies. In particular, the present disclosure provides prophylactic therapies comprising administration of an anti-IgE antibody at a specific dose to a human subject who is allergic to one or more food allergens.
    Type: Application
    Filed: September 17, 2025
    Publication date: June 18, 2026
    Applicants: Genentech, Inc., Novartis AG
    Inventors: Ryan Patrick OWEN, Ahmar IQBAL, Robert A. WOOD
  • Publication number: 20260167744
    Abstract: The present disclosure provides methods and kits for treating or preventing an allergic reaction to a food allergen consumed by a human subject with one or more food allergies. In particular, the present disclosure provides prophylactic therapies comprising administration of an anti-IgE antibody at a specific dose to a human subject who is allergic to one or more food allergens.
    Type: Application
    Filed: September 17, 2025
    Publication date: June 18, 2026
    Applicants: Genentech, Inc., Novartis AG
    Inventors: Ryan Patrick OWEN, Ahmar IQBAL, Robert A. WOOD
  • Patent number: 12492265
    Abstract: The present disclosure provides methods and kits for treating or preventing an allergic reaction to a food allergen consumed by a human subject with one or more food allergies. In particular, the present disclosure provides prophylactic therapies comprising administration of an anti-IgE antibody at a specific dose to a human subject who is allergic to one or more food allergens.
    Type: Grant
    Filed: February 10, 2025
    Date of Patent: December 9, 2025
    Assignees: Genentech, Inc., Novartis AG
    Inventors: Ryan Patrick Owen, Ahmar Iqbal, Robert A. Wood
  • Publication number: 20250179216
    Abstract: The present disclosure provides methods and kits for treating or preventing an allergic reaction to a food allergen consumed by a human subject with one or more food allergies. In particular, the present disclosure provides prophylactic therapies comprising administration of an anti-IgE antibody at a specific dose to a human subject who is allergic to one or more food allergens.
    Type: Application
    Filed: February 10, 2025
    Publication date: June 5, 2025
    Applicants: Genentech, Inc., Novartis AG
    Inventors: Ryan Patrick OWEN, Ahmar IQBAL, Robert A. WOOD
  • Publication number: 20250011474
    Abstract: The present disclosure provides methods and kits for treating or preventing an allergic reaction to a food allergen consumed by a human subject with one or more food allergies. In particular, the present disclosure provides prophylactic therapies comprising administration of an anti-IgE antibody at a specific dose to a human subject who is allergic to one or more food allergens.
    Type: Application
    Filed: July 2, 2024
    Publication date: January 9, 2025
    Applicants: Genentech, Inc., Novartis AG
    Inventors: Ryan Patrick OWEN, Ahmar IQBAL, Robert A. WOOD
  • Patent number: 12030959
    Abstract: The present disclosure provides methods and kits for treating or preventing an allergic reaction to a food allergen consumed by a human subject with one or more food allergies. In particular, the present disclosure provides prophylactic therapies comprising administration of an anti-IgE antibody at a specific dose to a human subject who is allergic to one or more food allergens.
    Type: Grant
    Filed: October 12, 2023
    Date of Patent: July 9, 2024
    Assignee: Genentech, Inc.
    Inventors: Ryan Patrick Owen, Ahmar Iqbal, Robert A. Wood
  • Publication number: 20220348687
    Abstract: The present invention features, inter alia, methods of treating a patient having asthma by administering an anti-tryptase antibody (e.g., anti-tryptase beta antibody) to the patient, anti-tryptase antibodies (e.g., anti-tryptase beta antibodies) for use in treating asthma, and uses of anti-tryptase antibodies (e.g., anti-tryptase beta antibodies), e.g., in the manufacture of medicaments for treating asthma.
    Type: Application
    Filed: September 18, 2020
    Publication date: November 3, 2022
    Inventors: Joseph Haw-Ling LIN, Ryan Patrick OWEN, Sharon Marie RYMUT, Siddharth SUKUMARAN